Publications:  Mr Neil Dufton

Dufton NP, Peghaire CR, Osuna-Almagro L, Raimondi C, Kalna V, Chauhan A, Webb G, Yang Y et al.(2020). Author Correction: Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis (Nature Communications, (2017), 8, 1, (895), 10.1038/s41467-017-01169-0). Nature Communications vol. 11, (1)

Peghaire C, Dufton NP, Lang M, Salles-Crawley II, Ahnström J, Kalna V, Raimondi C, Pericleous C et al.(2019). The transcription factor ERG regulates a low shear stress-induced anti-thrombotic pathway in the microvasculature. Nature Communications vol. 10, (1)

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO et al.(2018). Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis vol. 21, (3) 425-532.

Perbellini F, Watson SA, Scigliano M, Alayoubi S, Tkach S, Bardi I, Quaife N, Kane C et al.(2018). Investigation of cardiac fibroblasts using myocardial slices. Cardiovascular Research vol. 114, (1) 77-89.

Dufton NP, Peghaire CR, Osuna-Almagro L, Raimondi C, Kalna V, Chuahan A, Webb G, Yang Y et al.(2017). Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis. Nature Communications vol. 8, (1)

Shah AV, Birdsey GM, Peghaire C, Pitulescu ME, Dufton NP, Yang Y, Weinberg I, Osuna Almagro L et al.(2017). The endothelial transcription factor ERG mediates Angiopoietin-1-dependent control of Notch signalling and vascular stability. Nature Communications vol. 8,

Beuerle MG, Dufton NP, Randi AM, Gould IR(2016). Molecular dynamics studies on the DNA-binding process of ERG. Molecular BioSystems vol. 12, (12) 3600-3610.

Birdsey GM, Shah AV, Dufton N, Reynolds LE, Almagro LO, Yang Y, Aspalter IM, Khan ST et al.(2015). The endothelial transcription factor erg promotes vascular stability and growth through Wnt/β-catenin signaling. Developmental Cell vol. 32, (1) 82-96.

Vong L, Ferraz JGP, Dufton N, Panaccione R, Beck PL, Sherman PM, Perretti M, Wallace JL(2012). Up-regulation of Annexin-A1 and lipoxin A<inf>4</inf> in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS ONE vol. 7, (6)

Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC et al.(2011). Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental in-flammation (The Journal of Immunology (2010) 184, (2611-2619)). Journal of Immunology vol. 186, (4) 2684-2685.

Maderna P, Cottell DC, Toivonen T, Dufton N, Dalli J, Perretti M, Godson C(2010). FPR2/ALX receptor expression and internalization are critical for lipoxin A<inf>4</inf>and annexin-derived peptide-stimulated phagocytosis. FASEB Journal vol. 24, (11) 4240-4249.

Dufton N, Perretti M(2010). Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists. Pharmacology and Therapeutics vol. 127, (2) 175-188.

Yazid S, Ayoub SS, Solito E, McArthur S, Vo P, Dufton N, Flower RJ(2010). Anti-allergic drugs and the Annexin-A1 system. Pharmacol Rep vol. 62, (3) 511-517.

Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, Gray M, D'Acquisto F, Buckingham JC et al.(2010). Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental inflammation. Journal of Immunology vol. 184, (5) 2611-2619.

Maione F, Paschalidis N, Mascolo N, Dufton N, Perretti M, D'Acquisto F(2009). Interleukin 17 sustains rather than induces inflammation. Biochemical Pharmacology vol. 77, (5) 878-887.

Dufton NP, Hannon R, Perretti M, Flower R(2009). Quantitative Analysis of Promoter Activity by Green Fluorescent Protein (GFP) Target/Reporter Strategy in a Novel Transgenic alx/fpr-rs2 Null Mouse. Inflammation Research vol. 58, (2) S252-S255.